Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2011
09/14/2011CN101624376B Substituted hydrazide compound and application thereof
09/14/2011CN101163696B Histone deacetylase inhibitors
09/13/2011US8017770 Gas generant compositions
09/13/2011US8017641 P38 inhibitors and methods of use thereof
09/13/2011US8017639 Imidazole compounds
09/13/2011US8017625 Nitrogen-containing heteroaryl compounds and methods of use thereof
09/13/2011US8017614 Arylindenopyrimidines compound and use as an adenosine A2a receptor antagonists
09/13/2011US8017612 Piperazine compound and use thereof as a HCV polymerase inhibitor
09/13/2011US8017610 Phenylpyrrole derivative
09/13/2011US8017608 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors
09/13/2011US8017607 N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions
09/13/2011US8017601 Bis-aryl kinase inhibitors and method
09/13/2011US8017600 Imidazole compounds
09/13/2011US8017599 Sequence selective pyrrole and imidazole polyamide metallocomplexes
09/13/2011CA2670605C Substituted arylpyrazoles
09/13/2011CA2551168C 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
09/13/2011CA2528096C Cis-imidazolines as mdm2 inhibitors
09/13/2011CA2309260C 2,4-substituted pyrimidines and their use in herbicidal compositions
09/09/2011WO2011109470A1 Heteroaryl nitrile compounds useful as inhibitors of cathepsin-s
09/09/2011WO2011108612A1 Photoelectric conversion element and photoelectrochemical cell
09/09/2011WO2011107948A2 Ligands of insulin degrading enzyme and their uses
09/09/2011WO2011107919A1 Process for the direct preparation of malic acid salt of sunitinib
09/09/2011WO2011107530A2 Novel inhibitors
09/09/2011WO2011107504A1 Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants
09/09/2011WO2011107501A1 Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof
09/09/2011WO2011107474A1 Derivatives of aminoindanes, their preparation and their application in therapeutics
09/09/2011WO2011107248A1 NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE
09/09/2011WO2010123956A3 2,5-disubstituted arylsulfonamide ccr3 antagonists
09/09/2011CA2792039A1 Process for the direct preparation of malic acid salt of sunitinib
09/09/2011CA2791738A1 Compounds for treatment of cancer
09/09/2011CA2791431A1 Derivatives of aminoindanes, their preparation and their application in therapeutics
09/08/2011US20110218338 2-aminopyrimidine modulators of the histamine h4 receptor
09/08/2011US20110218276 N-alkoxylated 2,3-anthraquinonedicarboximides for polymer coloration, preparation and use
09/08/2011US20110218225 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
09/08/2011US20110218200 Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazine
09/08/2011US20110218188 Substituted (pyridyl)-azinylamine derivatives as fungicides
09/08/2011US20110218160 Arylalkylamine compound and process for preparing the same
09/08/2011US20110218103 Fluoroalkyl-substituted 2-amidobenzimidazoles
09/08/2011US20110217300 Quinazolinone Compounds and Methods of Use Thereof
09/08/2011US20110215715 Chrysene compounds for blue or green luminescent applications
09/08/2011DE102010009903A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices
09/07/2011EP2363398A1 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device
09/07/2011EP2363394A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
09/07/2011EP2363128A2 Indole modulators of ATP-binding cassette transporters
09/07/2011EP2362873A2 New crystal form of sunitinib malate
09/07/2011EP2049500B1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
09/07/2011EP1904442B1 Histamine h3 receptor agents, preparation and therapeutic uses
09/07/2011EP1877383B1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
09/07/2011CN1914182B Quinazoline derivatives
09/07/2011CN1777592B Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives
09/07/2011CN102177156A Methods for preparing oxazolidinones and compositions containing them
09/07/2011CN102177155A Process for preparing a 3-pyrrole subsituted 2-indolinone malate salt
09/07/2011CN102177154A Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators
09/07/2011CN102177152A Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
09/07/2011CN102177151A Modulators for amyloid beta
09/07/2011CN102177141A Bi-1H-benzimidazoles as hepatitis C virus inhibitors
09/07/2011CN102177136A Pyrrolidine N-benzyl derivatives
09/07/2011CN102174074A Inhabitors of cancer cell, T-cell and keratinocyte proliferation
09/07/2011CN102174024A 2,4-pyrimidinediamine compounds and their uses
09/07/2011CN102174022A 1-alkyl-2-substituted phenyl benzimidazole compound synthesis method and application
09/07/2011CN102174017A Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
09/07/2011CN101255154B Substituted 2-indoline ketone derivatives as well as preparation method and uses thereof
09/07/2011CN101193882B N-formyl hydroxylamine compounds as PDF inhibitor
09/07/2011CN101087766B Pyridazine compounds, compositions and methods
09/06/2011US8013168 Veliparib crystal structure; an anticancer PARP inhibitor
09/06/2011US8013156 Tie-2 modulators and methods of use
09/06/2011US8013154 Insecticidal substituted azinyl derivatives
09/06/2011US8013153 Substituted pyrimidine kinase inhibitors
09/06/2011US8012997 Isoindole-imide compounds, compositions, and uses thereof
09/06/2011US8012996 Methods and composition for inhibition of angiogenesis
09/06/2011US8012988 N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide
09/06/2011US8012985 Compounds with antiparasitic activity and medicines containing same
09/06/2011US8012969 11C-labeled benzyl-lactam compounds and their use as imaging agents
09/06/2011US8012965 e.g. 1-(2-chloro-7-methylthieno[3,2-d]pyrimidin-4-yl)-N3-(5,7-ethano-5,7,8-trihydro-6-methyl-1,6-naphthyridin-3-yl)-1H-1,2,4-triazole-3,5-diamine; angiogenesis inhibitor, antiproliferative agent
09/06/2011US8012959 Diaminopyrimidinecarboxamide derivative
09/06/2011CA2656875C Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
09/06/2011CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
09/06/2011CA2486872C Nf-kb inhibitors and uses thereof
09/06/2011CA2466965C Sulphonamide derivatives, their preparation and use as medicaments
09/06/2011CA2465746C Hydrazono-malonitriles
09/06/2011CA2439410C Analogs of thalidomide as potential angiogenesis inhibitors
09/01/2011WO2011106650A2 Novel p53-mdm2/p53-mdm4 antagonists to treat proliferative disease
09/01/2011WO2011105700A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/01/2011WO2011105572A1 Novel heteroaryl derivative
09/01/2011WO2011105161A1 Organic electroluminescent element
09/01/2011WO2011104555A2 Novel process
09/01/2011WO2011104322A1 Bisaryl-bonded aryltriazolones and use thereof
09/01/2011WO2011103933A1 PROCESS FOR THE PREPARATION OF α-ACYLOXY β-FORMAMIDO AMIDES
09/01/2011WO2011103932A1 A process for the preparation of substituted prolyl peptides and similar peptidomimetics
09/01/2011WO2011080684A4 Process for the preparation of candesartan cilexetil
09/01/2011WO2011073444A3 Azoline compounds for combating invertebrate pests
09/01/2011WO2011058521A4 Process for the preparation of crystalline form i of l-malic acid salt of sunitinib
09/01/2011WO2011027249A3 Benzimidazole derivatives
09/01/2011WO2010149309A3 Cycloalkylamidobenzoxa(thia)zoles as fungicides
09/01/2011WO2010141550A3 11beta-hydroxysteroid dehydrogenase type 1 (11-beta hsd1) inhibitors
09/01/2011US20110213003 Substituted hydroxamic acids and uses thereof
09/01/2011US20110212965 Inhibitors of Histone Deacetylase
09/01/2011US20110212962 P38 map kinase inhibitors
09/01/2011US20110212961 Pyrazole Derivatives as Kinase Inhibitors
09/01/2011US20110212937 Compounds for the reduction of beta-amyloid production